Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022 is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Centers for Disease Control
Grant: 75D30121C11529
Centers for Disease Control
Grant: 75D30121C12339
Centers for Disease Control
Grant: 75D30121C12246
Centers for Disease Control
Grant: 75D30121C11513
Centers for Disease Control
Grant: 75D30121C12279
Centers for Disease Control
Grant: 75D30121C11909
Centers for Disease Control
Grant: 75D30121C11519
National Institutes of Health
Grant: UL1TR001857
National Center for Advancing Translational Sciences
Grant: 5UL1TR002243-03
NCATS NIH HHS
Grant: UL1 TR002243
FWCI
2.39
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals